Department of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Dorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Methods Mol Biol. 2021;2193:129-140. doi: 10.1007/978-1-0716-0845-6_13.
Cardiovascular diseases (CVDs) are one of the leading causes of mortality worldwide and a number one killer in the USA. Cell-based approaches to treat CVDs have only shown modest improvement due to poor survival, retention, and engraftment of the transplanted cells in the ischemic myocardium. Recently, tissue engineering and the use of 3D scaffolds for culturing and delivering stem cells for ischemic heart disease are gaining rapid potential. Here, we describe a protocol for the fabrication of aligned coaxial nanofibrous scaffold comprising of a polycaprolactone (PCL) core and gelatin shell. Furthermore, we describe a detailed protocol for the efficient seeding and maintenance of human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) on these nanofibrous scaffolds, which could have a potential application in the generation of functional "cardiac patch" for myocardial repair applications as well as an in vitro 3D cardiac tissue model to evaluate the efficacy of cardiovascular drugs and cardiac toxicities.
心血管疾病 (CVDs) 是全球范围内导致死亡的主要原因之一,也是美国的头号杀手。由于移植细胞在缺血性心肌中的存活率、保留率和植入率低,基于细胞的方法治疗 CVDs 仅取得了适度的改善。最近,组织工程和使用 3D 支架培养和输送用于缺血性心脏病的干细胞正在迅速获得潜力。在这里,我们描述了一种制造包含聚己内酯 (PCL) 核和明胶壳的定向同轴纳米纤维支架的方案。此外,我们还描述了一种详细的方案,用于在这些纳米纤维支架上高效接种和维持人诱导多能干细胞衍生的心肌细胞 (hiPSC-CMs),这可能在生成功能性“心脏贴片”用于心肌修复应用以及评估心血管药物疗效和心脏毒性的体外 3D 心脏组织模型方面具有潜在应用。